Literature DB >> 8091460

Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates?

J W Mosley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8091460     DOI： 10.1046/j.1537-2995.1994.34994378271.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  4 in total

1.  Dot immunoperoxidase assay for detection of parvovirus B19 antigens in serum samples.

Authors:  G Gentilomi; M Musiani; M Zerbini; G Gallinella; S Venturoli; E Manaresi
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 2.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

3.  Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors.

Authors:  Janak Kishore; Manisha Srivastava; Nabjyoti Choudhary
Journal:  Asian J Transfus Sci       Date:  2010-07

4.  Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units.

Authors:  Janak Kishore; Manisha Srivastava; Nabajyoti Choudhury
Journal:  Asian J Transfus Sci       Date:  2011-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.